Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPP3CA | Q08209 | 6/20 | 0.65 |
| ▸ | PPIA | P62937 | 5/20 | 0.64 |
| ▸ | ABCB1 | P08183 | 10/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.61 |
| ▸ | GMNN | O75496 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 0.61 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | RARB | P10826 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.61 |
| ▸ | TACR2 | P21452 | 1/20 | 0.61 |
| ▸ | PPIB | P23284 | 1/20 | 0.61 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL97593 | 0.96 | PPP3CA (0.69) | PPP3CAPPIAABCB1MEN1NPC1 | |
| SCHEMBL9979458 | 0.86 | PPP3CA (0.78) | PPP3CAPPIAABCB1MEN1NPC1 | |
| SCHEMBL1081330 | 0.86 | PPP3CA (0.78) | PPP3CAPPIAABCB1MEN1NPC1 | |
| SCHEMBL97911 | 0.84 | PPIA (0.58) | PPP3CAPPIAABCB1MEN1NPC1 | |
| SCHEMBL9976367 | 0.81 | PPP3CA (0.52) | PPP3CAPPIAABCB1MEN1NPC1 | |
| SCHEMBL9929319 | 0.81 | PPP3CA (0.69) | PPP3CAPPIAABCB1MEN1NPC1 | |
| SCHEMBL9929320 | 0.81 | PPP3CA (0.69) | PPP3CAPPIAABCB1MEN1NPC1 | |
| SCHEMBL9929241 | 0.81 | PPP3CA (0.69) | PPP3CAPPIAABCB1MEN1NPC1 | |
| SCHEMBL9929244 | 0.81 | PPP3CA (0.69) | PPP3CAPPIAABCB1MEN1NPC1 | |
| SCHEMBL97589 | 0.80 | PPIA (0.78) | PPP3CAPPIAABCB1MEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120058932-A1 | ACTIVE INGREDIENT-PEPTIDE CONSTRUCT FOR EXTRACELLULAR CONCENTRATION | MAX PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058932-A1 | ACTIVE INGREDIENT-PEPTIDE CONSTRUCT FOR EXTRACELLULAR CONCENTRATION | VIP, FIBP, MMP7 | PPP3CA 4171/4885PPIA 1604/4885ABCB1 1204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.